Doctor profile · Federal record
Dr. David Harris, M.D.
Endocrinology, Diabetes & Metabolism Physician · Tulsa, OK
- NPI 1831176106
- MIPS 79.4 / 100 · 2023
- 21 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6160 S Yale Ave
Tulsa, OK 741361930
(918) 495-2628
fax (918) 495-2610 - Mailing address
-
6600 S Yale Ave, Ste 1400
Tulsa, OK 741363310
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- September 16, 2015
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Oklahoma #14906
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831176106. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,096
Distinct HCPCS
5
Medicare allowed
$106,304
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 676 | 308 | $120 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 230 | 99 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 136 | 113 | $84 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 30 | 30 | $158 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 24 | 23 | $53 |
In context: peer comparison
Among 8 peers in Tulsa Endocrinology, Diabetes & Metabolism Physician, average services per provider: 168. This provider delivers 6.5× the peer median.Open Payments
Industry payments received
All-time total
$77
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tandem Diabetes Care, INC. | 1 | $27.70 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $24.55 | |
| Amgen INC. | 1 | $24.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,115
Patients
574
Total drug cost
$1,873,962
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 319 | 90 | $4,960 |
| Ozempic (Semaglutide) | Brand | 260 | 52 | $354,144 |
| Trulicity (Dulaglutide) | Brand | 196 | 38 | $291,396 |
| Novolog Flexpen (Insulin Aspart) | Brand | 184 | 61 | $265,541 |
| Metformin Hcl | Generic | 142 | 39 | $2,004 |
| Synthroid (Levothyroxine Sodium) | Brand | 127 | 34 | $15,138 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 122 | 37 | $111,992 |
| Levemir Flexpen (Insulin Detemir) | Brand | 110 | 38 | $114,899 |
| Januvia (Sitagliptin Phosphate) | Brand | 104 | 21 | $106,064 |
| Glimepiride | Generic | 103 | 33 | $1,790 |
Frequently asked questions
What is Dr. David Harris's medical specialty?
Dr. David Harris practices Endocrinology, Diabetes & Metabolism Physician in Tulsa, OK.
Where does Dr. David Harris practice?
Dr. David Harris practices at 6160 S Yale Ave, Tulsa, OK 741361930. Office phone: 9184952628.
What is Dr. David Harris's NPI?
Dr. David Harris's National Provider Identifier (NPI) is 1831176106, issued by NPPES.
What procedures does Dr. David Harris commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.